Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (131-140 of 1,288) with videos related to

Pageof 129
Sort By:
Maryland Medical Journal (Baltimore, Md. : 1985)|February 1, 1996
Clear and present danger: a medical-legal dilemmaE G Elias, A J Keating
Quarterly Journal of Experimental Physiology and Cognate Medical Sciences|October 1, 1970
The ipsilateral retinotectal pathway in the frogM J Keating, R M Gaze
Quarterly Journal of Experimental Physiology and Cognate Medical Sciences|April 1, 1970
Observations on the 'surround' properties of the receptive fields of frog retinal ganglion cellsM J Keating, R M Gaze
Leukemia & Lymphoma|September 13, 2012
Selection of rituximab dosage in chronic lymphocytic leukemia: where is the evidence?Constantine S Tam, Michael J Keating
The Medical Journal of Australia|June 29, 1974
Prognosis of acute leukaemia in adultsD G Penington, M J Keating
American Journal of Veterinary Research|March 25, 2021
Cardiopulmonary effects of an intravenous infusion of fentanyl in cats during isoflurane anesthesia and with concurrent acepromazine or dexmedetomidine administration during anesthetic recoveryStephanie C J Keating, Carolyn L Kerr
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosineW Plunkett, S Iacoboni, M J Keating
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemiaS O'Brien, H Kantarjian, M J Keating
Seminars in Oncology|February 1, 2017
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Expert Review of Anticancer Therapy|October 6, 2006
Monoclonal antibodies in chronic lymphocytic leukemiaAlessandra Ferrajoli, Stefan Faderl, Michael J Keating
Pageof 129

Showing results (131-140 of 1,288) with videos related to

Sort By:
Pageof 129
Maryland Medical Journal (Baltimore, Md. : 1985)|February 1, 1996
Clear and present danger: a medical-legal dilemmaE G Elias, A J Keating
Quarterly Journal of Experimental Physiology and Cognate Medical Sciences|October 1, 1970
The ipsilateral retinotectal pathway in the frogM J Keating, R M Gaze
Quarterly Journal of Experimental Physiology and Cognate Medical Sciences|April 1, 1970
Observations on the 'surround' properties of the receptive fields of frog retinal ganglion cellsM J Keating, R M Gaze
Leukemia & Lymphoma|September 13, 2012
Selection of rituximab dosage in chronic lymphocytic leukemia: where is the evidence?Constantine S Tam, Michael J Keating
The Medical Journal of Australia|June 29, 1974
Prognosis of acute leukaemia in adultsD G Penington, M J Keating
American Journal of Veterinary Research|March 25, 2021
Cardiopulmonary effects of an intravenous infusion of fentanyl in cats during isoflurane anesthesia and with concurrent acepromazine or dexmedetomidine administration during anesthetic recoveryStephanie C J Keating, Carolyn L Kerr
Scandinavian Journal of Haematology. Supplementum|January 1, 1986
Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosineW Plunkett, S Iacoboni, M J Keating
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemiaS O'Brien, H Kantarjian, M J Keating
Seminars in Oncology|February 1, 2017
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Expert Review of Anticancer Therapy|October 6, 2006
Monoclonal antibodies in chronic lymphocytic leukemiaAlessandra Ferrajoli, Stefan Faderl, Michael J Keating
Pageof 129